Symbols

EOLS

Evolus·NASDAQ

--(--)

EOLS Profile

Evolus, Inc.

A beauty company that provides medical aesthetic products in the US

Industry

Pharmaceutical

Established Date

Listing Date

02/08/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

334

Fiscal Year Ends

12-31

Website

www.evolus.com

Security Type

Common stock

Office address

520 Newport Center Dr., Suite 1200, Newport Beach, California 92660

Business

Introduction

Evolus, Inc., was incorporated in Delaware in November 2012. The company is a global efficacy beauty company focusing on the self-funded medical beauty market, providing injectable products to licensed beauty practitioners. Its main product, Jeuveau, is a purified botulinum toxin type A for temporarily improving the eyebrow lines, while the company is developing Evolysse, a series of hyaluronic acid gels for injection for facial beauty applications.